|
TAF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.771800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.774230E-01 |
| Normal-vs-Stage2 |
4.811800E-01 |
| Normal-vs-Stage3 |
6.717000E-01 |
| Normal-vs-Stage4 |
9.576400E-01 |
| Stage1-vs-Stage2 |
7.428600E-01 |
| Stage1-vs-Stage3 |
3.204200E-02 |
| Stage1-vs-Stage4 |
1.750010E-01 |
| Stage2-vs-Stage3 |
2.672600E-01 |
| Stage2-vs-Stage4 |
4.952000E-01 |
| Stage3-vs-Stage4 |
6.244000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.198400E-01 |
| Normal-vs-AfricanAmerican |
9.559800E-01 |
| Normal-vs-Asian |
7.015800E-04 |
| Caucasian-vs-AfricanAmerican |
6.207600E-01 |
| Caucasian-vs-Asian |
3.403100E-03 |
| AfricanAmerican-vs-Asian |
7.683500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.964600E-01 |
| Normal-vs-Female |
1.578620E-01 |
| Male-vs-Female |
8.120100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.054600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.975370E-01 |
| Normal-vs-Age(61-80Yrs) |
5.952200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.591220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.294800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.829000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.426600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.016000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.694300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.960500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.121200E-03 |
| Normal-vs-Grade 2 |
7.073900E-02 |
| Normal-vs-Grade 3 |
9.540000E-01 |
| Normal-vs-Grade 4 |
3.381200E-01 |
| Grade 1-vs-Grade 2 |
7.253800E-02 |
| Grade 1-vs-Grade 3 |
1.935240E-03 |
| Grade 1-vs-Grade 4 |
5.177500E-04 |
| Grade 2-vs-Grade 3 |
1.485970E-02 |
| Grade 2-vs-Grade 4 |
8.761500E-03 |
| Grade 3-vs-Grade 4 |
2.572400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.716400E-02 |
| Normal-vs-ccB subtype |
9.116600E-01 |
| ccA subtype-vs-ccB subtype |
8.855900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.170600E-01 |
| Normal-vs-N1 |
9.131800E-01 |
| N0-vs-N1 |
8.996600E-01 |
|
|
